The policy designates pharmaceutical and health product advertising as a restricted category requiring pre-authorization, prohibits false or misleading health claims, and requires that ads include applicable regulatory disclosures and comply with FDA or equivalent national guidelines.
This analysis describes what Pinterest Ads's agreement states, permits, or reserves. It does not constitute a legal determination about enforceability. Regulatory applicability and practical outcomes may vary by jurisdiction, enforcement context, and individual circumstances. Read our methodology
This provision creates a compound compliance obligation for health and pharmaceutical advertisers: obtaining Pinterest's internal authorization, satisfying applicable FDA or equivalent regulatory standards for promotional claims, and including required disclosures, with Pinterest's approval not constituting regulatory clearance.
Interpretive note: The policy references FDA, EMA, and equivalent national authority guidelines but does not specify which claims formats or disclosure standards satisfy these requirements on Pinterest's specific ad formats, creating interpretive uncertainty about implementation.
Under these terms, health and pharmaceutical advertisers must obtain Pinterest pre-authorization and independently ensure their campaigns comply with applicable FDA or national regulatory guidelines for health claims; Pinterest's ad approval does not satisfy regulatory disclosure requirements.
How other platforms handle this
Ads for prescription drugs are only allowed in certain countries and advertisers must be certified by Google. Ads must comply with applicable laws and industry standards in the locations where the ads are shown.
Advertisers promoting products or services in regulated categories including alcohol, financial products, gambling, healthcare and pharmaceuticals, and dating services must comply with Snap's category-specific policies, obtain any required pre-authorization, include required legal disclosures, and c...
Monitoring
Pinterest Ads has changed this document before.
Receive same-day alerts, structured change summaries, and monitoring for up to 10 platforms.
"Ads for pharmaceuticals, over-the-counter drugs, health supplements, and medical devices are a restricted category requiring prior authorization from Pinterest. Ads must not make false or misleading health claims, must include required regulatory disclosures where applicable, and must comply with applicable FDA, EMA, or equivalent national regulatory authority guidelines.— Excerpt from Pinterest Ads's Pinterest Advertising Guidelines
(1) REGULATORY LANDSCAPE: FDA regulations govern pharmaceutical promotional materials in the US, including requirements for fair balance disclosures and prohibition on off-label promotion for prescription drugs. FTC regulations govern health claims for supplements, OTC products, and wellness devices, requiring that claims be substantiated by competent and reliable scientific evidence. EMA-aligned national regulations govern pharmaceutical promotion in EU member states, with country-specific variations in requirements for direct-to-consumer advertising. (2) GOVERNANCE EXPOSURE: High for pharmaceutical and health supplement advertisers. The combination of Pinterest's pre-authorization requirement, the platform's prohibition on misleading health claims, and the advertiser's independent FDA or regulatory compliance obligation creates a multi-layer review requirement that must be addressed before campaign launch. (3) JURISDICTION FLAGS: Direct-to-consumer prescription drug advertising is generally permitted in the US subject to FDA requirements but is largely prohibited in the EU; advertisers running international campaigns must configure geographic targeting to comply with these jurisdiction-specific restrictions. Canada's PAAB guidelines create additional requirements for pharmaceutical advertising served to Canadian users. (4) CONTRACT AND VENDOR IMPLICATIONS: Pharmaceutical manufacturers and their agency partners should establish documented processes for obtaining Pinterest authorization and maintaining records of regulatory review for health claims used in Pinterest campaigns. Medical communications agencies should ensure their Pinterest campaign review processes include regulatory affairs sign-off as a mandatory precondition to launch. (5) COMPLIANCE CONSIDERATIONS: Compliance teams should assess whether their Pinterest health and supplement campaigns include all required FDA or FTC disclosures in formats compatible with Pinterest's ad creative specifications. Teams should also verify that Pinterest's geographic targeting controls are configured to enforce jurisdiction-specific restrictions on pharmaceutical advertising formats.
Full compliance analysis
Regulatory citations, enforcement risk, and due diligence action items.
Free: track 1 platform + weekly digest. Monitor: 10 platforms + same-day alerts. No credit card required.
Compliance Governance Intelligence
Need to monitor specific governance provisions?
Compliance includes provision-level monitoring, governance timelines, regulatory mapping, and audit-ready analysis.
Built from archived source documents, structured governance mappings, and historical version tracking.
This provision creates a compound compliance obligation for health and pharmaceutical advertisers: obtaining Pinterest's internal authorization, satisfying applicable FDA or equivalent regulatory standards for promotional claims, and including required disclosures, with Pinterest's approval not constituting regulatory clearance.
Under these terms, health and pharmaceutical advertisers must obtain Pinterest pre-authorization and independently ensure their campaigns comply with applicable FDA or national regulatory guidelines for health claims; Pinterest's ad approval does not satisfy regulatory disclosure requirements.
No. ConductAtlas is an independent monitoring service. We are not affiliated with, endorsed by, or sponsored by Pinterest Ads.